Protocol Number: 98-C-0037

Title:

Evaluation, Treatment, and Natural History of Children with Cancer

Number:

98-C-0037

Summary:

This protocol is designed to evaluate children with cancer who appear to be probable candidates for future protocol entry or have disease manifestations that are of unique scientific importance or educational value.

Sponsoring Institute:

National Cancer Institute (NCI)

Recruitment Detail

Type: Active Accrual Of New Subjects

Gender: Male & Female

Referral Letter Required: Yes

Population Exclusion(s): None

Eligibility Criteria:

INCLUSION CRITERIA:

Patients who are evaluated by the Pediatric Oncology Branch and are:

Children with cancer (or a precancer syndrome), between the age(s) of 3 months to 30 years, who are evaluated by the Pediatric Oncology Branch and are found to be not immediately eligible for an ongoing protocol but are likely to become a candidate for a future protocol.

Patients between the ages of 30 and 40 years may be evaluated on this protocol if their cancer (or precancer syndrome) is of specific interest to the Pediatric Oncology Branch.

Patients with cancer (or a precancer syndrome), who present with disease manifestations of special interest to Pediatric Oncology Branch investigators, because they are likely to shed light on disease pathogenesis or natural history.

Patients with cancer (or a precancer syndrome) who offer an important educational benefit to trainees in pediatric oncology.

If indicated, availability of a parent or legal guardian to give informed consent. Patients, and, when indicated, parent or legal guardian who are deemed sufficiently reliable to return for recommended follow-up visits.

EXCLUSION CRITERIA:

Patients younger than 3 months of age.

Special Instructions: Currently Not Provided

Keywords:

Lymphoma

Sarcoma

Leukemia

Brain Tumors

Ewing's Sarcoma

Neuroectodermal Tumors

Osteosarcoma

Rhabdomyosarcoma

Children

Recruitment Keywords:

None

Conditions:

Ewing's Sarcoma

Leukemia

Lymphoma

Neoplasm

Sarcoma

Investigational Drug(s):

None

Investigational Device(s):

None

Contacts:

CSSC
Clinical Studies Support Center/NCI
164 Rollins Avenue
2nd FLoor
Rockville, MD 20852
Phone: (888) 624-1937
Fax: (301) 881-8239

Electronic Address: ncicssc@mail.nih.gov

Citations: Not Provided

• Questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
• Technical questions regarding the Clinical Center web site, please contact the Department of Networks and Applications, CC.

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

Warren Grant Magnuson Clinical Center (CC)
National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/16/2004